TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Celularity ( (CELU) ).
On July 21, 2025, Celularity Inc. issued a promissory note worth $6,812,230 to an investor, along with a warrant to purchase 3,700,000 shares of Class A common stock at $2.528 per share, exercisable for five years. The note, bearing a 2% annual interest rate and maturing on March 21, 2026, is secured by the company’s assets and will be partially used to settle a loan from C.V. Starr & Co. This financial maneuver is expected to impact Celularity’s operations by addressing existing debt obligations and potentially influencing its market positioning.
Spark’s Take on CELU Stock
According to Spark, TipRanks’ AI Analyst, CELU is a Neutral.
The stock’s overall score is driven by strong technical momentum, despite weak financial performance and unattractive valuation. The company’s high leverage and negative cash flows are areas of concern, but recent price momentum indicates investor interest.
To see Spark’s full report on CELU stock, click here.
More about Celularity
Average Trading Volume: 246,415
Technical Sentiment Signal: Buy
Current Market Cap: $78.55M
Find detailed analytics on CELU stock on TipRanks’ Stock Analysis page.